supp.fit

Maitake Mushroom: study protocols

5 study groups say how much Maitake Mushroom participants took a day. These are the doses the studies gave. They are not a recommendation.

Maitake Mushroom: what the research found →

Dose per serving from products

231 products in our catalogue print how much Maitake Mushroom a serving holds.

Most common: 100 mg to 250 mg, 39% of 231 products.

Dose per servingProducts
10 mg or less
9
10 mg to 25 mg
63
25 mg to 50 mg
31
50 mg to 100 mg
20
100 mg to 250 mg
90
250 mg to 500 mg
9
over 500 mg
9

Dose per serving from research

5 study groups in 1 study say how much Maitake Mushroom participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 5 mg/kg to 10 mg/kg, 40% of 5 study groups.

Daily doseStudy groups
0.25 mg/kg or less
1
0.25 mg/kg to 0.5 mg/kg
0
0.5 mg/kg to 1 mg/kg
1
1 mg/kg to 2.5 mg/kg
0
2.5 mg/kg to 5 mg/kg
1
5 mg/kg to 10 mg/kg
2

Commonly used together

None of these 5 study groups took Maitake Mushroom with anything else.

5 study groups

Study
A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects
2009 · 0.1 mg/kg cohort · Postmenopausal women with breast cancer, free of disease after initial treatment
0.2 mg/kg3 weeks—
A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects
2009 · 0.5 mg/kg cohort · Postmenopausal women with breast cancer, free of disease after initial treatment
1 mg/kg3 weeks—
A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects
2009 · 1.5 mg/kg cohort · Postmenopausal women with breast cancer, free of disease after initial treatment
3 mg/kg3 weeks—
A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects
2009 · 3 mg/kg cohort · Postmenopausal women with breast cancer, free of disease after initial treatment
6 mg/kg3 weeks—
A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects
2009 · 5 mg/kg cohort · Postmenopausal women with breast cancer, free of disease after initial treatment
10 mg/kg3 weeks—
Maitake Mushroom: study protocols | supp.fit